Acrivon Therapeutics
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors (NCT06667141) | Acrivon Therapeutics | 2024-10-08 |
| A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma (NCT05548296) | Acrivon Therapeutics | 2022-08-29 |
Track Acrivon Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.